These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19764029)

  • 1. Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice.
    Hill CA; Sussan TE; Reeves RH; Richtsmeier JT
    Am J Med Genet A; 2009 Oct; 149A(10):2158-65. PubMed ID: 19764029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.
    Sumarsono SH; Wilson TJ; Tymms MJ; Venter DJ; Corrick CM; Kola R; Lahoud MH; Papas TS; Seth A; Kola I
    Nature; 1996 Feb; 379(6565):534-7. PubMed ID: 8596630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice.
    Starbuck JM; Dutka T; Ratliff TS; Reeves RH; Richtsmeier JT
    Am J Med Genet A; 2014 Aug; 164A(8):1981-1990. PubMed ID: 24788405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
    Richtsmeier JT; Baxter LL; Reeves RH
    Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome.
    Richtsmeier JT; Zumwalt A; Carlson EJ; Epstein CJ; Reeves RH
    Am J Med Genet; 2002 Feb; 107(4):317-24. PubMed ID: 11840489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome.
    Billingsley CN; Allen JR; Baumann DD; Deitz SL; Blazek JD; Newbauer A; Darrah A; Long BC; Young B; Clement M; Doerge RW; Roper RJ
    Am J Med Genet A; 2013 Aug; 161A(8):1866-74. PubMed ID: 23843306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway.
    Wolvetang EJ; Wilson TJ; Sanij E; Busciglio J; Hatzistavrou T; Seth A; Hertzog PJ; Kola I
    Hum Mol Genet; 2003 Feb; 12(3):247-55. PubMed ID: 12554679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased male reproductive success in Ts65Dn "Down syndrome" mice.
    Moore CS; Hawkins C; Franca A; Lawler A; Devenney B; Das I; Reeves RH
    Mamm Genome; 2010 Dec; 21(11-12):543-9. PubMed ID: 21110029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome.
    Sussan TE; Yang A; Li F; Ostrowski MC; Reeves RH
    Nature; 2008 Jan; 451(7174):73-5. PubMed ID: 18172498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Olson LE; Richtsmeier JT; Leszl J; Reeves RH
    Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS family of genes in leukemia and Down syndrome.
    Papas TS; Watson DK; Sacchi N; Fujiwara S; Seth AK; Fisher RJ; Bhat NK; Mavrothalassitis G; Koizumi S; Jorcyk CL
    Am J Med Genet Suppl; 1990; 7():251-61. PubMed ID: 2149958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models.
    Aldridge K; Reeves RH; Olson LE; Richtsmeier JT
    Am J Med Genet A; 2007 May; 143A(10):1060-70. PubMed ID: 17431903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome.
    Wolvetang EW; Bradfield OM; Tymms M; Zavarsek S; Hatzistavrou T; Kola I; Hertzog PJ
    Biochim Biophys Acta; 2003 Jul; 1628(2):105-10. PubMed ID: 12890557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome.
    Yang A; Reeves RH
    Cancer Res; 2011 May; 71(10):3573-81. PubMed ID: 21467166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies.
    Chatterjee A; Dutta S; Mukherjee S; Mukherjee N; Dutta A; Mukherjee A; Sinha S; Panda CK; Chaudhuri K; Roy AL; Mukhopadhyay K
    BMC Med Genet; 2013 Jan; 14():12. PubMed ID: 23343470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.
    McElyea SD; Starbuck JM; Tumbleson-Brink DM; Harrington E; Blazek JD; Ghoneima A; Kula K; Roper RJ
    Hum Mol Genet; 2016 Nov; 25(22):4856-4869. PubMed ID: 28172997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome.
    Paz-Miguel JE; Flores R; Sánchez-Velasco P; Ocejo-Vinyals G; Escribano de Diego J; López de Rego J; Leyva-Cobián F
    J Immunol; 1999 Nov; 163(10):5399-410. PubMed ID: 10553065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner.
    Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ
    Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.